17
(b) increased on a pro forma basis by an amount equal to the Financial Indebtedness directly attributable to (i) any Financial Indebtedness owed by acquired entities, and (ii) any Financial Indebtedness incurred to finance the acquisition of such entities, in each case to the extent attributable to the Reference Period or the period from the end of the Reference Period to the relevant testing date (for the avoidance of doubt, any cash balance resulting from the incurrence of the Financial Indebtedness shall not reduce Net Interest Bearing Debt); and
(c) increased on a pro forma basis by an amount equal to the Financial Indebtedness (the incurrence of which requires that the Incurrence Test is made) incurred after the last day of the Reference Period and the amount equal to the Financial Indebtedness in respect of which the Incurrence Test is made (for the avoidance of doubt, any cash balance resulting from the incurrence of the new Financial Indebtedness shall not reduce Net Interest Bearing Debt).
12.4 Equity Cure
(a) Subject to paragraphs (b) to (e) below, the Issuer may prevent an Event of Default occurring as a result of a breach of the Leverage Ratio Maintenance Test by an equity injection to the Issuer made by way of a share issue or an unconditional shareholder contribution (an "Equity Cure").
(b) The full cash amount of the Equity Cure shall be deemed to have been applied as an increase of EBITDA as at the relevant Reference Date in respect of which the Leverage Ratio Maintenance Test is made, whereupon the Leverage Ratio Maintenance Test shall be recalculated to include the effect of the Equity Cure. Provided that the amount of the Equity Cure contributed to the Issuer is sufficient to prevent the breach of the Leverage Ratio Maintenance Test, no Event of Default shall be deemed to have occurred.
(c) The Equity Cure must be made within twenty (20) Business Days of delivery of a Compliance Certificate evidencing the breach ofthe Leverage Ratio Maintenance Test.
(d) The Equity Cure shall be deemed to have been received on the Reference Date falling on last day of the Reference Period and shall be included in the calculation of the Leverage Ratio Maintenance Test until such time as that Reference Date falls outside the Reference Period.
(e) Any Equity Cure must be contributed in cash to the Issuer and no more than three (3) Equity Cures may be made over the lifetime of the Bonds. Equity Cures may not be injected in respect of any consecutive calendar quarters.
